Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

44
Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013 Bernard GOUGET Member, Committee Health Care Section [email protected] Fédération Hospitalière de France

description

Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013 Bernard GOUGET Member, Committee Health Care Section [email protected] Fédération Hospitalière de France. - PowerPoint PPT Presentation

Transcript of Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Page 1: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Patient Safety and Accreditation of Medical Laboratories in France

Friday, April 12, 2013

Bernard GOUGETMember, Committee Health Care Section

[email protected]édération Hospitalière de France

Page 2: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

• What was the project about?

The European Network for Patient Safety (EUNetPaS) project established a network of all 27 EU Member States, international organisations, and stakeholders in the field of healthcare (healthcare professionals, patients, institutions, and scientists) to encourage and enhance collaboration in the field of patient safety. It was coordinated by HAS (the French National Authority for Health).

• Project’s objectives•

The objectives of the project were:• To promote coherence at the EU level through recommendations and common tools• To promote a patient safety culture based on no-blame reporting• To promote education and information on patient safety• To create a permanent collaboration network on patient safety

• Project’s outcomes

• Outcomes of the project include a tool to measure patient safety culture, guidelines for education and training, a virtual library of European reporting and learning systems, recommendation on medication safety and an establishment of national Patient Safety Platforms in 13 EU Member States.

Page 3: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Promoting Quality and Patient safetyPromoting Quality and Patient safetyThe need for common tools and terminologyThe need for common tools and terminology

• Patient safety is now on the healthcare agenda in most western countries

• Patient safety is a somewhat nebulous concept to many, and there is a need for a simple conceptual framework so that patient safety may be placed in context with respect to other healthcare activities

Definition:• Patient safety is a discipline in the health care professions that applies safety

science methods toward the goal of achieving a trustworthy system of health care delivery

Page 4: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Patient safety in contextPatient safety in context

• Patient safety is an important component of risk management, clinical governance, and quality improvement.

• The quality improvement systems provide a basis for introducing the necessary changes for patient safety from reaction to prevention

Page 5: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The HPST law(hospital, patient, health and territories)

The law was passed in July 2009 to reorganize the French health care system . The main objectives were:

- to modernize the hospitals, giving them more financial means to carry out their mission and to reorganize their territorial and internal organization,

- to promote research and education,

- to guarantee a better access to care,

- to reorganize the provision of care through a coordination between the hospitals and cities within a regional organization,

- and to promote public health.

Page 6: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The Med Lab is increasingly integrated with patient care

• The increasing demand for:

– Transparency and Accountability,– Accessibility,– Integrated diagnostics– Professional excellence, – Patient outcomes and Customer satisfaction, – and better cost management

has underpinned the development of systems for quality assurance with an increasing focus on accreditation and several forms of external review mechanisms .

Page 7: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The French contextThe French context• 10 000 medical biologists• 16,5/100 000 inhabitants vs 5,8 in UE• 7000 private sector / 3000 hospital

• Medical Lab demogaphy is decreasing• ¾ pharmaceutical ; ¼ medical background

• 41 000 people are working the the private sector

• 3800 private labs• 1200 Hospital labs• There is a movement for concentrating laboratories,

increasingly pursued by investment funds.

Page 8: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Medical Biology in France : Medical Biology in France : Economic aspectsEconomic aspects

• 1,8% routine health care expenses

• 2,4% Consumption of care and medical goods • ( 4,3 BM € private sector, 2,2 BM € public )

• 9,7% Consumption of ambulatory health care

• -1,6% decrease in reimbursements

FR gross domestic product (GDP):2033,7 BM€

Page 9: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

History of the French reform of History of the French reform of the medical labs the medical labs

• 2009: HPST: Art 69 de la loi n° 2009-879 du 21 juillet 2009 portant réforme de l'hôpital et relative aux patients, à la santé et aux territoires

• 2010: Ordonnance Janvier 13 2010 (REGULATION)

• 2011: Proposition de loi de M. Jean-Pierre Fourcade modifiant certaines dispositions de la loi n° 2009-879 du 21 juillet 2009 portant réforme de l'hôpital et relative aux patients, à la santé et aux territoires (n° 65, 2010-2011), censurées par le Conseil constitutionnel.

• 2012: l'Assemblée nationale le 26 janvier 2012, Une proposition de loi de Mme Valérie Boyer, M. Jean-Luc Préel et plusieurs de leurs collègues portant réforme de la biologie médicale (n° 3989, AN XIIIème législature), reprenant le même texte, a été adoptée

• 2012: Sénat fev 2012, sans toutefois être inscrite à l'ordre du jour avant la fin de la législature.

• 2013: 10 avril Commission Mixte Paritaire > Ratification Jeudi 11 Avril 2013 Sénat ( LAW)

Page 10: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Four major objectives of the new lawFour major objectives of the new law

• to ratify the 2010 ordinance regarding laboratory medicine

• to enhance the medicalization of the profession.

• to define the organization of laboratory medicine

• and slow the Intrusive process of the finance industry

• to ensure the quality of medical biology tests.

Page 11: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Medicalization of the professionMedicalization of the profession

• In order to be recognized as a medical biologist, it is necessary to hold a pharmacist or medical degree and a degree in specialized studies in laboratory medicine.

• The conduct of the preanalytical phase of a laboratory medicine test is secured

by guidance from the practice of providers ( nurses) authorized to participate in it.

• Adjustments have also been made at various points, especially regarding the question of the practice of healthcare providers coming from the European Union and not holding a medical biology degree

• Consistent with the fact that laboratory medicine is a medical discipline rather than a technical one, the practice is ended of exceptions to the pricing rules by common law acts, called "rebates (discounts)", excluding cooperation between public institutions.

Page 12: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Territorial organization of the medical labsTerritorial organization of the medical labs

• Articles define the organization of laboratory medicine on 3 territories

• One article seeks to slow the Intrusion of the finance industry by restoring the principle of majority ownership of company capital by medical biologists practicing within companies.

• Regional health agencies are responsible for regulating the provision of public and private laboratory medicine in the regions where they operate, in order to guarantee that local laboratory medicine is sustained.

JIQH 2009 – La Villette 23 & 24 novembre 2009 Page 12

Page 13: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Multisite labsMultisite labs• Rule :

Only one multisite lab in one hospital or hospital group

• Accreditation consequences– 1 responsible– Multisite quality

management– Homogenization of pre-

examination procedures

Territorial multisite

laboratory

« Star » model with unique central lab

« Network » modelwith multiple

connected labs

Page 14: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

POCT POCT

– Objectives

• Remote control

• Training-Habilitation

• A posteriori biological validation

• Unified procedures

– One POC coordinator

– Mandatory accreditationNF ISO EN 22870

POCCoordinator

TnIcED BNP

MICU

BGICU

pHNICU

HbDig.ICU

ACTOR

Page 15: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Optimiser le maillage territorial Optimiser le maillage territorial (6)(6)Groupements validés par l’ARS pour le SROS BiologieGroupements validés par l’ARS pour le SROS Biologie

2 sites 1 PT 21 MB B:0.25

4 sites ? PT 47 MB B:0.24

4 sites 2 PT 38 MB B:0.21

6 sites ? PT 39 MB B:0.28

2 sites 2 PT 31 MB B:0.23

Données RTC 2010

ARS

Page 16: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Mandatory accreditationMandatory accreditation

• .One article sets a double objective regarding laboratory accreditation,

• It ensures that medical biologists have an optimal organization in place and are proven to be competent to conduct testing:

• As of November 2016, medical laboratories will not be able to operate without an accreditation covering 50% of medical biology tests.

• As of November 1, 2018, medical laboratories will not be able to operate without an accreditation covering 70% of medical biology tests.

• As of November 1, 2020, medical laboratories will not be able to operate without an accreditation covering 100% of medical biology tests.

• The accreditation in principle cover all families of tests.

JIQH 2009 – La Villette 23 & 24 novembre 2009 Page 16

Page 17: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

French accreditation projectFrench accreditation project

– NF EN ISO 15189

– NF EN ISO 228 70

17

Page 18: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

and the mandatory accreditation for and the mandatory accreditation for medical labsmedical labs

based on ISO 15189 and ISO 22870 standards the whole activity of the laboratory is concerned

Need for adaptations at the accreditation body level and at the laboratory level

Page 18

Page 19: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The CofracThe Cofrac

Unique national accreditation body recognized by law

In compliance with the European Regulation n° 765/2008 dated 9 July 2008 : accreditation is a public authority activity

the national accreditation body operates on a not-for-profit basis

all interested parties are involved in the work of the national accreditation body

the national accreditation body fulfils the requirements of ISO/IEC 17011, particularly in terms of independence , impartiality, transparency, competence of its personnel

Passed with success the peer evaluation organized by EA and is signatory to the EA-MLA

Page 19

Page 20: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The CofracThe Cofrac

Boardof Administrators

Quality Manager

General Director

InternalAudit Commission

Lead assessors and technical assessors

InspectionSection

LaboratoriesSection

CertificationsSections

Healthcare Section

Horizontal services: accounting, human resources, communication,..

Page 20

Page 21: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

This section is totally dedicated to human health issues

The section committee participates in the elaboration of the strategy for accreditation of medical laboratories as well as in the working of the documents useful to evaluation and accreditation

The technical commission for accreditation studies evaluation reports and looks at the candidatures of technical evaluators and experts

These two instances are composed of:

representatives from the ministry of Health, its permanent offices in regions, the High Authority of Health, medical biologists, patients, prescribers, accredited medical laboratories.

The Healthcare SectionThe Healthcare Section

Page 21

Page 22: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The evaluatorsThe evaluators

Accreditation is based upon evaluations undertaken by peers

Selecting a candidate to become a technical evaluator consists in validating his capability to evaluate as well as the adequacy of his technical competence to our needs

The selected technical evaluators are working in medical laboratories accredited or on the way to be accredited.

Page 22

Page 23: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The evaluatorsThe evaluators

The evaluators (lead and technical) used by Cofrac fill a declaration of confidentiality and absence of conflicts of interest.

If justified, a medical laboratory may refuse to be evaluated by a proposed evaluator.

The evaluators are trained and supervised periodically.

Page 23

Page 24: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The accreditation cycleThe accreditation cycle

I S1 S2 S3 R

S4

S5

S6

15 months

5 years

12 months

I: Initial evaluation R: ReevaluationSn: Surveillance visitExt: Extension evaluation

Page 24

Ext

12 months 12 months 12 months

15 months

15 months15 months

Page 25: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The accreditation The accreditation processprocess

Multisite accreditation has to be put in place• Only one dossier• Unique quality management system• Organization taking into account the multisite reality• Flexible scope

Specific evaluation of the preanalysis activity carried out by medical auxiliaries (nurses, ...)

Specific evaluation for point of care testing

Page 25

Page 26: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The accreditation The accreditation processprocess

The 3 steps are:

analysis and formalization of the demand

evaluation (documentary and on site) of the competences of the medical laboratory

decision on the basis of the evaluation report

Page 26

Page 27: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

On site evaluationOn site evaluation

Key points :

Examination of the relevance and adequacy of the arrangements in place, both at the organisational and technical levels

Verification of the good application of the arrangements

Evaluation of the technical competence (through interviews and observations) as well as of the quality of the results (through internal or external controls)

Page 27

Page 28: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

On site evaluationOn site evaluation

Outcome: general impressions aiming to conclude on the

confidence in the quality of the exams– strengths– possibilities for improvements

Eventual findings

All conclusions and findings are presented during the closing meeting

The laboratory may accept/refuse the finding reported by the evaluator

Page 28

Page 29: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

On site evaluationOn site evaluation

Critical non conformity: non conformity that has an impact on the reliability of the results or on the capability of the management system to maintain the quality level of the exam.

Non critical non conformity: non conformity that has no direct and immediate impact on the quality of the exams

For each non conformity, an action plan is required from the laboratory.

Page 29

Page 30: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The decision processThe decision process

The evaluation reports are studied collegially by accreditation commissions,

The decision is taken by the Cofrac General Director,

An appeal procedure permits contestation of the decision by the laboratory.

Page 30

Page 31: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The decision processThe decision process

In case of initial evaluation or extension evaluation

• if it exists critical non conformities not under control: negative decision or negative until verification (documentary or on site) of the effectiveness of the corrective actions

• the non conformities must be cleared up within 6 months at a maximum

• after expiration of this delay, the laboratory gets:- 15 days to transmit documentary proofs,- 3 months to have a complementary evaluation.

Page 31

Page 32: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

The decision processThe decision process

In case of surveillance visit or re-evaluation• If it exists critical non conformities not under control: positive

decision only if they are cleared up within 3 months at a maximum

• after expiration of this delay, the laboratory gets:- 15 days to transmit documentary proofs,- 3 months to have a complementary evaluation.

• the non critical non conformities must be cleared up within 6 months at a maximum.

Page 32

Page 33: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Information about accreditation decisions have to be transmitted to several public entities

When there is a major risk for the health of the patients, the regional permanent office of the ministry of health is immediately informed.

InformationInformation

Page 33

Page 34: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Accreditation manualAccreditation manual

Document grouping accreditation requirements together with those coming from the regulation

The manual contains explanatory notes and recommendations

Aim : to facilitate common understanding of the rules by laboratories and evaluators.

Page 34

Page 35: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Accredited laboratories

31/12/09 31/12/10 31/12/11 31/12/12 28/02/13

Nb de structures accréditées 156 153 185 206 212*

(nb de sites) (156) (197) (319) (510) (581)

dont structures hospitalières - 11 14 13 15

dont structures accréditées selon la norme NF EN ISO 15189

- 59 129 182 190

dont structures accréditées selon la norme NF EN ISO 22870

- - 2 2 2

* dont 18 non LBM (structures ACP, structures médico-légales, …)

Page 36: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

36

Etude réalisée sur 2000 écarts (en 2012/2013) relevés sur des évaluations réalisées selon la norme NF EN ISO 15189 & SH REF 02

Bilan statistique (mars 2012/janvier 2013)

Total Non critique Critique Maîtrise avant passage en commission

(critique)

Qualité 619 ( 30 %)286 (34%)*

580270

39 (2%)16 (6 %)

22 (56 %)7 (44 %)

Technique 1380 (70 %)568 (66 %)

1234500

146 (10%)68 (12%)

65 (44%)32 (47 %)

Réunion d'harmonisation des Evaluateurs Techniques- Section Santé Humaine - Cofrac – 2013

* Données du bilan 2011/2012

Page 37: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

37

Etude réalisée sur 2000 écarts (en 2012/2013) relevés sur des évaluations réalisées selon la norme NF EN ISO 15189 & SH REF 02

Bilan statistique (mars 2012/janvier 2013)

Total Non critique Critique Maîtrise avant passage en commission

(critique)

Qualité 619 ( 30 %)286 (34%)*

580270

39 (2%)16 (6 %)

22 (56 %)7 (44 %)

Technique 1380 (70 %)568 (66 %)

1234500

146 (10%)68 (12%)

65 (44%)32 (47 %)

Réunion d'harmonisation des Evaluateurs Techniques- Section Santé Humaine - Cofrac – 2013

* Données du bilan 2011/2012

Page 38: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Requirements of ISO 15189Requirements of ISO 15189

Page 39: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

39Réunion d'harmonisation des Evaluateurs Techniques- Section Santé Humaine - Cofrac – 2013

Page 40: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

40Réunion d'harmonisation des Evaluateurs Techniques- Section Santé Humaine - Cofrac – 2013

Page 41: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

41Réunion d'harmonisation des Evaluateurs Techniques- Section Santé Humaine - Cofrac – 2013

Page 42: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

42Réunion d'harmonisation des Evaluateurs Techniques- Section Santé Humaine - Cofrac – 2013

Page 43: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013

Thank you !Thank you !

Page 43

Page 44: Patient Safety and Accreditation of Medical Laboratories in France Friday, April 12, 2013